LOLIPOP trial funding win

05 February 2024

The Australian-led LOLIPOP trial has received $A3.8 million from the UK’s National Institute for Health and Care Research. The trial aims to reduce post-surgical pain for breast cancer patients.

The Australian-led LOLIPOP trial has received $A3.8 million from the UK’s National Institute for Health and Care Research. The trial aims to reduce post-surgical pain for breast cancer patients.

The success of the LOLIPOP UK grant led by Perth-based anaesthetist Associate Professor Andrew Toner is a result of a collaboration between the Australian study team and UK investigators with Associate Professor Mark Edwards at University Hospital Southampton NHS Foundation Trust and Bristol Trials Centre at the University of Bristol.

Read the latest media release.


Last updated 16:02 5.02.2024